EVFM - Evofem Biosciences, Inc.

QQQ $ 451.63 $ -0.22 (-0.05 %)

DIA $ 399.76 $ 0.74 (0.19 %)

SPY $ 529.24 $ 0.76 (0.14 %)

TLT $ 91.40 $ -0.62 (-0.67 %)

GLD $ 223.63 $ 3.63 (1.65 %)

Previous Close

$ 0.0145

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.01 - $ 1.40

Volume

4,412,543

Average Volume

Market Cap

452,319

Beta (5Y Monthly)

$ 1.37

PE Ratio (TTM)

$ 0.01

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-27-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	06-16-2023	03-31-2023	10-Q
6	04-27-2023	12-31-2022	10-K
7	01-06-2023	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-11-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	03-04-2021	12-31-2020	10-K
15	11-09-2020	09-30-2020	10-Q
16	08-04-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	03-01-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-14-2018	03-31-2018	10-Q
26	02-26-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-23-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-12-2016	03-31-2016	10-Q
34	03-29-2016	12-31-2015	10-K
35	11-12-2015	09-30-2015	10-Q
36	08-13-2015	06-30-2015	10-Q
37	05-14-2015	03-31-2015	10-Q
38	03-26-2015	12-31-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Aditxt Said On April 26 Received Notice Fr...
05/03/2024 10:05:21

-8-K

'France becomes first country to explicitl...
03/04/2024 17:53:02

https://www.washingtonpost.com/world/2024/03/04/france-abortion-constitution/

Laidlaw & Co. Downgrades Evofem Bioscience...
12/13/2023 09:25:56

Laidlaw & Co. analyst Yale Jen downgrades Evofem Biosciences (OTC:EVFM) from Buy to Hold.

why-is-life-sciences-focused-aditxt-stock-trading-higher-today

Why Is Life Sciences-Focused Aditxt Stock ...
12/12/2023 15:18:59

Aditxt Inc (NASDAQ: ADTX) has agreed to acquire Evofem Biosciences Inc (OTC: EVFM) in consideration of the issuance of a combin...

Aditxt, Inc. Enters Into Definitive Agreem...
12/12/2023 13:34:29

Evofem posted $13.4 million in net sales of Phexxifor the first nine months of 2023;Aditxt looks to accelerate Evofem into the ...

Evofem Biosciences Announces Padagis Will ...
09/27/2023 12:49:05

-- Padagis Determined They Will Not Challenge the Phexxi Patents -- -- Evofem Has Phexxi Patent Protection Through 2033 --

Evofem Biosciences Plans 1-For-125 Reverse...
05/17/2023 20:52:20

On Thursday May 18, 2023, the Company's common stock will open for trading under a new CUSIP (30048L302) on the OTC Venture...

Florida Lawmakers Approve Six-Week Abortio...
04/13/2023 20:40:51

-Reuters

Costco Adds Phexxi To Member Prescription ...
01/10/2023 13:40:10

Evofem Biosciences, Inc. (OTCQB:EVFM) today announced that Phexxi® (lactic acid, citric acid, potassium bitartrate) has been ad...

Evofem Biosciences's Return On Capital Emp...
01/09/2023 14:45:12

Georgia Supreme Court Reinstates State's B...
11/23/2022 17:00:40

- Reuters

Abortion Opponents Sue FDA And HHS, Seekin...
11/18/2022 18:42:32

- WSJ

Benzinga's Top Ratings Upgrades, Downgrade...
10/13/2022 14:05:37

Upgrades

Stifel Downgrades Evofem Biosciences to Ho...
10/13/2022 09:38:02

Stifel analyst Annabel Samimy downgrades Evofem Biosciences (OTC:EVFM) from Buy to Hold and lowers the price target from $3 ...

why-evofem-biosciences-shares-are-plunging-today

Why Evofem Biosciences Shares Are Plunging...
10/12/2022 18:17:25

Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100)...

Evofem Announces Issuance Of U.S. Patent C...
09/23/2022 13:02:15

-- Issuance of U.S. Patent No. 11,439,610 Further Strengthens Evofem's Intellectual Patent Portfolio -- -- Newly Issued Pa...

'West Virginia governor signs abortion ban...
09/16/2022 17:48:23

https://twitter.com/ZekeJMiller/status/1570831511469060096

evofem-biosciences-return-on-capital-employed-overview

Evofem Biosciences Return On Capital Emplo...
08/18/2022 14:05:00

4 Analysts Have This to Say About Evofem B...
08/15/2022 14:10:24

Over the past 3 months, 4 analysts have published their opinion on Evofem Biosciences (OTC:EVFM) stock. These analysts are t...

HC Wainwright & Co. Maintains Buy on Evofe...
08/15/2022 10:37:40

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Evofem Biosciences (OTC:EVFM) with a Buy and raises the price t...